These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 4398309)

  • 1. Factors affecting drug metabolism.
    Gillette JR
    Ann N Y Acad Sci; 1971 Jul; 179():43-66. PubMed ID: 4398309
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P-450 and its role in drug metabolism.
    Gillette JR; Davis DC; Sasame HA
    Annu Rev Pharmacol; 1972; 12():57-84. PubMed ID: 4114185
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of mixed oxygenases and nitroreductase in drug metabolism.
    Gillette JR
    Ann N Y Acad Sci; 1969 Oct; 160(2):558-70. PubMed ID: 4390499
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between NADH and NADPH oxidation during drug metabolism.
    Sasame HA; Mitchell JR; Thorgeirsson S; Gillette JR
    Drug Metab Dispos; 1973; 1(1):150-5. PubMed ID: 4129866
    [No Abstract]   [Full Text] [Related]  

  • 5. [P-450 cytochrome. Detoxication by liver microsomes].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(23):1587-92. PubMed ID: 4402521
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of spironolactone on drug metabolism by hepatic microsomes.
    Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors involved in the inhibition of drug metabolism by (-)-emetine.
    Johnson RK; Mazel P; Donahue JD; Jondorf WR
    Biochem Pharmacol; 1971 May; 20(5):955-66. PubMed ID: 4400643
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of adrenalectomy and cortisone administration on components of the liver microsomal mixed function oxygenase system of male rats which catalyzes ethylmorphine metabolism.
    Castro JA; Greene FE; Gigon P; Sasame H; Gillette JR
    Biochem Pharmacol; 1970 Aug; 19(8):2461-7. PubMed ID: 4398649
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions.
    Hildebrandt A; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):66-79. PubMed ID: 4397839
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron transport components of hepatic microsomes. Solubilization, resolution, and recombination to reconstitute aniline hydroxylase activity.
    Fujita T; Mannering GJ
    J Biol Chem; 1973 Dec; 248(23):8150-6. PubMed ID: 4148101
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidation-reduction mechanisms of cytochrome P-450.
    Miyake Y; Mori K; Yamano T
    Biochem Biophys Res Commun; 1971 Aug; 44(3):564-70. PubMed ID: 4399360
    [No Abstract]   [Full Text] [Related]  

  • 12. On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain.
    Franklin MR; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):318-29. PubMed ID: 4397835
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the effects of halothane and CCl 4 on the hepatic drug metabolizing system.
    Davis DC; Schroeder DH; Gram TE; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):556-66. PubMed ID: 4398189
    [No Abstract]   [Full Text] [Related]  

  • 14. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cycloheximide on the mixed-function oxidase system of cat liver.
    Williams JF; Karler R
    Mol Pharmacol; 1971 May; 7(3):269-79. PubMed ID: 4398360
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
    Davies DS; Thorgeirsson SS
    Ann N Y Acad Sci; 1971 Jul; 179():411-20. PubMed ID: 5285386
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of temperature on the relationship between hepatic microsomal cytochrome P-450 reduction and ethylmorphine demethylation.
    Schroeder DH; Gram TE; Gillette JR
    Pharmacology; 1971; 5(5):295-300. PubMed ID: 4397379
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.
    Feller DR; Gerald MC
    Biochem Pharmacol; 1971 Aug; 20(8):1991-2000. PubMed ID: 4400282
    [No Abstract]   [Full Text] [Related]  

  • 20. The temperature dependence of the components of the hepatic microsomal mixed-function oxidases.
    Holtzman JL; Carr ML
    Arch Biochem Biophys; 1972 May; 150(1):227-34. PubMed ID: 4402151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.